BACKGROUND: Little is known about the effects of antipsychotic medications on gray matter (GM) in schizophrenia. Although clozapine remains the most effective antipsychotic medication in treatment-refractory cases, it is unknown whether it has a differential effect on GM development. METHODS: In an exploratory analysis, we used automated cortical thickness measurements and prospectively scanned childhood-onset schizophrenia (COS) patients who were maintained on one medication. Two atypical antipsychotic medications, clozapine (n=12, 37 scans) and olanzapine (n=12, 33 scans) were compared with respect to effects on cortical development, in contrast to GM trajectories of matched controls. RESULTS: There were no significant differences in the trajectories of cortical thickness between the two treatment groups with the exception of a small circumscribed area in the right prefrontal cortex, where the olanzapine group showed thicker cortex. As expected, both groups showed thinner GM compared to matched controls. CONCLUSIONS: Although these analyses do not rule out effects of antipsychotic medications on GM development in schizophrenia, they show no differential effect between clozapine and olanzapine on GM trajectory.
BACKGROUND: Little is known about the effects of antipsychotic medications on gray matter (GM) in schizophrenia. Although clozapine remains the most effective antipsychotic medication in treatment-refractory cases, it is unknown whether it has a differential effect on GM development. METHODS: In an exploratory analysis, we used automated cortical thickness measurements and prospectively scanned childhood-onset schizophrenia (COS) patients who were maintained on one medication. Two atypical antipsychotic medications, clozapine (n=12, 37 scans) and olanzapine (n=12, 33 scans) were compared with respect to effects on cortical development, in contrast to GM trajectories of matched controls. RESULTS: There were no significant differences in the trajectories of cortical thickness between the two treatment groups with the exception of a small circumscribed area in the right prefrontal cortex, where the olanzapine group showed thicker cortex. As expected, both groups showed thinner GM compared to matched controls. CONCLUSIONS: Although these analyses do not rule out effects of antipsychotic medications on GM development in schizophrenia, they show no differential effect between clozapine and olanzapine on GM trajectory.
Authors: Vicente Molina; Santiago Reig; Javier Sanz; Tomás Palomo; Carlos Benito; Javier Sánchez; Fernando Sarramea; Javier Pascau; Manuel Desco Journal: Schizophr Res Date: 2005-09-16 Impact factor: 4.939
Authors: Philip Shaw; Alex Sporn; Nitin Gogtay; Gerald P Overman; Deanna Greenstein; Peter Gochman; Julia W Tossell; Marge Lenane; Judith L Rapoport Journal: Arch Gen Psychiatry Date: 2006-07
Authors: Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao Journal: N Engl J Med Date: 2005-09-19 Impact factor: 91.245
Authors: Nitin Gogtay; Anna Ordonez; David H Herman; Kiralee M Hayashi; Deanna Greenstein; Cathy Vaituzis; Marge Lenane; Liv Clasen; Wendy Sharp; Jay N Giedd; David Jung; Tom F Nugent; Arthur W Toga; Ellen Leibenluft; Paul M Thompson; Judith L Rapoport Journal: J Child Psychol Psychiatry Date: 2007-09 Impact factor: 8.982
Authors: Babak Khorram; Donna J Lang; Lili C Kopala; Robert A Vandorpe; Qing Rui; Vina M Goghari; Geoffrey N Smith; William G Honer Journal: Am J Psychiatry Date: 2006-11 Impact factor: 18.112
Authors: Nitin Gogtay; Deanna Greenstein; Marge Lenane; Liv Clasen; Wendy Sharp; Pete Gochman; Philip Butler; Alan Evans; Judith Rapoport Journal: Arch Gen Psychiatry Date: 2007-07
Authors: L J S Schweren; C A Hartman; M P Zwiers; D J Heslenfeld; D van der Meer; B Franke; J Oosterlaan; J K Buitelaar; P J Hoekstra Journal: Eur Child Adolesc Psychiatry Date: 2014-11-14 Impact factor: 4.785
Authors: Brian Weisinger; Deanna Greenstein; Anand Mattai; Liv Clasen; Francois Lalonde; Sara Feldman; Rachel Miller; Julia W Tossell; Nora S Vyas; Reva Stidd; Christopher David; Nitin Gogtay Journal: Schizophr Bull Date: 2011-05-25 Impact factor: 9.306
Authors: C I Giakoumatos; P Nanda; I T Mathew; N Tandon; J Shah; J R Bishop; B A Clementz; G D Pearlson; J A Sweeney; C A Tamminga; M S Keshavan Journal: J Psychiatr Res Date: 2014-12-23 Impact factor: 4.791
Authors: Anand A Mattai; Brian Weisinger; Deanna Greenstein; Reva Stidd; Liv Clasen; Rachel Miller; Julia W Tossell; Judith L Rapoport; Nitin Gogtay Journal: J Am Acad Child Adolesc Psychiatry Date: 2011-06-11 Impact factor: 8.829